INTRODUCTION 48
Classical Congenital Adrenal Hyperplasia (CAH) is most commonly due to a mutation in 49 the CYP21A2 gene, affecting 1 in 15,000 live births, and is the most common cause of primary 50 adrenal insufficiency in children (1) . Inadequate production of cortisol and aldosterone, and 51 overproduction of adrenal androgens, starting in the first trimester in utero can manifest in 52 female newborns with the severe, classical forms of CAH as masculinized external genitalia 53 (2, 3) . Given widespread expression of androgen and glucocorticoid receptors throughout the 54 brain (4,5), there has been interest in understanding how hormonal imbalances related to CAH 55 may impact distinct subregions of the developing brain (6) . Several studies have begun to 56 examine brain and behavioral alterations associated with CAH, with reported differences in 57 emotional and memory processes in CAH patients. These include moderate-to-large reductions 58 in short-term and working memory, which involve the hippocampus (7, 8) . Utilizing 59 neuroimaging, abnormal amygdala volumes have been reported in children with CAH (9), with 60 affected females exhibiting greater amygdala activity during functional magnetic resonance 61 imaging (fMRI) emotional tasks (10) compared to control females (11). Adolescents with CAH 62 also differ in their aversive ratings of fearful faces (11), exhibit poorer memory for negatively 63 valenced stimuli on fMRI as compared to controls (10, 12) , and have impaired motivational 64 inhibition on a reward-based anti-saccade task (13) . Higher rates of anxiety disorders are also 65 reported in youth with CAH compared to nationwide rates in healthy or other chronically ill 66 pediatric populations (14) . More recently, women (18-50 years) affected by CAH due to 21-67 hydroxylase deficiency were also found to have reduced hippocampal volumes and impaired 68 cognitive performance on working memory and processing speed tests (15) . 69
Both the amygdala and hippocampus are comprised of heterogenous cell types that can 70 be categorized into subregions with distinct cytoarchitecture, with previous studies showing 71 functional differences between the basal and lateral nuclei (which process high-level sensory 72 input and emotional regulation) (16, 17) and the central and basolateral nuclei (which are 73 involved in reward learning and food intake) (18) . Similarly, both structural and functional MRI 74 studies have reported that hippocampal subfields, including the CA1, CA3, and dentate gyrus 75 (DG), may have different involvement in learning and memory processes (19, 20) . The amygdala 76 and hippocampus have both efferent and afferent connectivity with the prefrontal cortex (PFC), 77 ultimately allowing for successful emotional regulation and learning and memory behaviors 78 (21, 22) . However, it has yet to be studied how the distinct subregions of the amygdala and 79 hippocampus are affected in patients with CAH. 80 The goal of the current study was to utilize state-of-the-art, high-resolution neuroimaging 81 techniques to more fully characterize gray matter morphometry of the PFC, hippocampus, and 82 amygdala in youth with classical CAH, compared to age-and sex-matched controls. CAH 83 provides the opportunity to further understand how alterations in prenatal androgen and cortisol 84 deficiency, as well as postnatal androgen and glucocorticoid exposure, may impact the 85 developing brain. By combining 3D high-resolution T1-and T2-weighted structural sequences, 86 there is substantial improvement of structural MRI to capture tissue contrast, which subsequently 87 allows for enhanced segmentation of the amygdala into eight distinct subnuclei [lateral nucleus, 88 basal nucleus, accessory basal nucleus, anterior amygdaloid area, medial nucleus, cortical 89 nucleus, cortico-amygdaloid transition, and paralaminar nucleus] (23) and the hippocampus into 90 six subfields [parasubiculum, presubiculum, subiculum, CA1, CA3, and DG] (24) . 91
PARTICIPANTS AND METHODS 92

Study Participants 93
The study was cross-sectional and approved by the Institutional Review Board Health-related exclusionary criteria for all participants included prenatal drug or alcohol 100 exposure, premature birth, serious medical illness (other than CAH), eating disorders, or 101 psychotropic medication. Participants were screened for any significant neurological conditions 102 (e.g., epilepsy and traumatic head injury) and psychiatric/developmental disorders (e.g., autism, 103 attention deficit hyperactive disorder, schizophrenia, and self-harm tendencies) which, if present, 104 barred participation. Participants were also screened for any factors that would prevent proper 105 and safe usage of MRI, such as irremovable ferrous materials (e.g., braces), uncorrectable vision 106 impairments (e.g., blind spots and colorblindness), need for hearing aids, or claustrophobia. 107
We studied a total of 62 children and adolescents between the ages of 8 and 18 years old 108 at the time of their visit (Table 1) , including 27 participants with classical CAH and 35 age-and 109 sex-matched healthy controls with no significant medical conditions. Youth with CAH had either 110 the salt-wasting (n=25) or simple-virilizing form (n=2), as diagnosed by positive newborn screen 111 (n=12), or biochemically and/or by genotype (n=15; age of testing 11.2 ± 27.4 months). At the 112 time of the study visit, patients with CAH were on daily glucocorticoid dosing (16.5 ± 4.7 113 mg/m 2 /day) with glucocorticoid dose equivalencies calculated based on growth-suppressing 114 effects of longer-acting glucocorticoids compared to hydrocortisone (prednisone dose was 115 multiplied by 5 and dexamethasone dose was multiplied by 80) (25). Almost all patients (n=26) 116 were also treated with fludrocortisone (0.11 ± 0.04 mg/day). 117
Anthropometric measures of height (cm) and weight (kg) were obtained in all 118 participants. Pubertal Tanner staging was assessed by a pediatric endocrinologist. Body mass 119 index (BMI) and BMI z-score were calculated by SAS based on 2000 Center for Disease Control 120
Growth Chart data (26, 27) . A radiograph of the left hand was used to determine bone age (BA) 121 using the Greulich-Pyle method (28) and read in a blinded fashion by a single pediatric 122 endocrinologist (M.S.K.). BA SD was determined utilizing digital software (29). BA was 123 obtained at the time of the study visit, or within several months of the visit if taken for clinical 124 purposes. The individuals who had completed growth at the time of the study visit had their BA 125
x-rays reviewed for earlier full maturity as adolescents. 126
There were no significant differences between the groups in terms of handedness, 127 ethnicity/race composition, family income, maternal education, or IQ, as assessed by the 128 Wechsler Adult Intelligence Scale (WASI) IV two-subtest test (30). Pubertal development was 129 not significantly different between the two groups, although patients with CAH had higher BMI 130 and BMI z-scores, as well as BA SD for their chronological age, as compared to control youth. 131
After an overnight fast (12 h), and prior to routine morning medications in CAH youth, all 132 participants had had their blood drawn at the CHLA Clinical Trials Unit for measurement of 133 analytes including: 17-hydroxyprogesterone, androstenedione, plasma renin activity, and total 134 testosterone by liquid chromatography tandem mass spectrometry (Quest Diagnostics Nichols 135 Institute, San Juan Capistrano, CA). 136
Magnetic Resonance Imaging (MRI) Acquisition 137
All images were collected on a Siemens Magnetom Prisma 3 Tesla MRI scanner using a 138 32-channel head coil at University of Southern California's Center for Image Acquisition. T1-139 weighted structural imaging was acquired using a sagittal whole brain MPRAGE sequence (TR = 140 2400 ms, TE = 2.22 ms, flip angle = 8°, BW = 220 Hz/Px, FoV = 256 mm, 208 slices, and 0.8-141 mm isotropic voxels, with a GRAPPA phase-encoding acceleration factor of 2). T2-weighted 142 variable flip angle turbo spin-echo sequence was also collected (TR = 3200 ms, TE = 563 ms, 143 BW = 744 Hz/Px, FoV = 256 mm, 208 slices, 0.8-mm isotropic voxels, and 3.52-ms 144 echospacing, with a GRAPPA phase-encoding acceleration factor of 2). Anterior-posterior and 145 posterior-anterior spin echo field maps were also obtained (TR = 8000 ms, TE = 66.0 ms, flip 146 angle = 90°, BW = 2290 Hz/Px, FoV = 208 mm, 72 slices, and 2.0-mm isotropic voxels, with a 147 multi-band acceleration factor of 1). A radiologist reviewed all scans for incidental findings of 148 gross abnormalities. 149
MRI Analysis 150
Whole Brain Segmentation 151
Structural image processing, including whole brain segmentation with automated labeling 152 of different neuroanatomical structures, was performed using FreeSurfer v6.0 153 (http://surfer.nmr.mgh.harvard.edu) (31,32). Standard quality control procedures were as 154 follows: 1) all raw images were visually inspected for motion prior to processing and 2) post-155 processed images were visually inspected by a trained operator for accuracy of segmentation for 156 each scan per participant (33). No manual intervention (i.e., subcortical editing) was performed. 157
In addition to total gray matter, cerebrospinal fluid (CSF) and intracranial (ICV) volume were 158 extracted as well as five a priori prefrontal regions of interest (ROI) using the Desikan-Killiany 159 Atlas, including the superior, rostral middle, caudal middle, lateral orbitofrontal, and medial 160 orbitofrontal regions for both the right and left hemisphere. established that a contrast-to-noise ratio (CNR) > 1 provides a robust estimation of the ground 174 truth volumes. Using their established formula, the CNR for our sample was 1.21 and 1.01 for 175 the T1-and T2-weighted scans suggesting that we had sufficient CNR to establish amygdala 176 boundaries using this method. 177 T1-and T2-weighted images for each participant were also utilized to quantify six 178 hippocampal subfields, including the parasubiculum, presubiculum, subiculum, CA1, CA3, and 179 dentate gyrus (DG) using the computational atlas (24) available in FreeSurfer v6.0 (31). This 180 method provides hippocampal subfield volumetric measures that more closely align with 181 histological measurements, compared to alternative automated segmentation algorithms and 182 previous versions of the software (24).
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In addition to absolute volumes of amygdala subnuclei and hippocampal subfields, we 184 calculated a relative volume fraction (RVF) for each ROI by normalizing it to the respective total 185 amygdala volume in each hemisphere (ROI probabilistic volume divided by total amygdala 186 probabilistic volume). In addition to examining overall differences in volume, RVF allows for 187 determining if the amygdala or hippocampal relative composition differed in youth affected with 188 CAH as compared to controls (e.g., testing if within the amygdala the proportions of each nuclei 189 are relatively smaller or larger to other nuclei). 190
Statistical Analyses 191
All data analyses were performed in Rstudio v1.2 (Boston, MA http://www.rstudio.com/) 192 using linear multiple regression and linear-mixed models from package nlme v3.1 193 (https://CRAN.R-project.org/package=nlme). Given group differences in BMI z-scores, BA SD, 194 and ICV (Tables 1 and 2) , these variables were included as covariates in all subsequent analyses 195 when applicable. Separate multiple regressions were first implemented to examine how group, 196 sex, and their interaction (group*sex) predicted CSF and ICV, while controlling for BMI z-score 197 and BA SD. In addition, similar models were performed for each a priori PFC and total 198 amygdala and hippocampus volumes for the right and left hemispheres, while adjusting means 199 for BMI z-score, BA SD, and ICV. To assess amygdala subnuclei and hippocampal subfields, 200 separate multi-level models were then performed to investigate group (CAH vs control) and 201 group-by-region effects for both the absolute volumes and RVF of the eight amygdala subnuclei 202 and six hippocampal subfields across both hemispheres (right, left), with the within-subject 203 variable, while also controlling for BMI z-score, BA SD, and ICV (for absolute volumes). Post-204 hoc tests were then performed to probe significant interactions (group-by-region), correcting for 205 multiple comparisons using the Holm method. Lastly, for regions showing significant group 206 differences in brain structure, a within-group assessment of relationships between brain structure 207 and clinical features was performed in youth with CAH using multiple regression. These clinical 208 features included: BA SD, testosterone and androstenedione levels, and glucocorticoid daily dose 209 (mg/m 2 /day). 210
RESULTS 211
Central Nervous System Abnormalities 212
During radiology review, one CAH patient was found to have a Type 1 Chiari 213 malformation, and two CAH patients were found to have arachnoid cysts, with one cyst located 214 near the temporal lobe and the other near the cerebellum. Because central nervous system 215 abnormalities have been previously reported in patients with CAH (15), analyses were performed 216 including these participants; however, follow-up analyses were also examined excluding the data 217 from these three patients to ensure they were not driving group effects. Sample characteristics 218 were similar between the groups when excluding the three CAH patients with brain anomalies. 219
Total Brain Volumes 220
A significant main effect was seen for both ICV and CSF, with youth with CAH having 221 smaller ICV, but larger CSF volumes, compared to controls (Table 2, Figure 1A and 1B). No 222 significant differences were seen in overall cortical gray matter ( Figure 1C ). For the medial 223 temporal lobe volumes, total amygdala and hippocampus volumes were smaller on average in 224 CAH youth compared to controls, although in statistical testing only the total left hippocampus 225 volume was significantly smaller in CAH (p = 0.01). (Table 2, Figure 2A 2C and D). A trend was also seen in smaller right lateral orbitofrontal volumes in CAH youth 229 compared to controls, which did not reach statistical significance (p = 0.07). Group-by-sex 230 effects were not significant in any of the models (data not shown). 231
Amygdala Subnuclei and Hippocampal Subfields 232
Significant group [F(1,55) = 11.70, p = 0.001, η p² = 0.006] and group-by-region 233 interactions [F(8,1020) = 5.64, p < 0.0001, η p² = 0.03] were seen in the absolute volumes for 234 amygdala subnuclei ( Figure 3A ). Follow-up post-hoc analyses revealed that the largest amygdala 235 subnucleus, the LA, was significantly smaller in CAH patients as compared to controls (Table 3 , 236 Figure 3A ). No main effect of group [F(1,55) = 0.08, p = 0.77, η p² < 0.001] or group-by-region 237 interaction [F(8,1020) = 1.16, p = 0.32, η p² = 0.008] was seen for amygdala RVF (Table 3 , 238 Figure 3A ). 239
Significant group [F(1,56) = 8.99, p = 0.004, η p² = 0.02] and group-by-region 240 interactions [F(5,671) = 7.80, p < 0.0001, η p² = 0.03] were also seen in the absolute volumes for 241 the hippocampal subfields ( Figure 3B ). Follow-up post-hoc analyses revealed that the subiculum 242 and CA1 subfields were significantly smaller in CAH youth compared to controls ( Figure 3B ). 243
For hippocampal RVF, the overall main effect of group was not significant [F(1,57) = 1.82, p = 244 0.18, η p² = 0.002], but the group-by-region interaction was significant [F(6,671) = 5.07, p < 245 0.0001, η p² = 0.03] ( Figure 3B ). Even after accounting for smaller hippocampal volumes, the 246 presubiculum, subiculum, and CA1 were proportionately smaller, whereas CA3 was 247 proportionately larger, relative to overall hippocampal volumes in CAH patients as compared to 248 controls. 249
Brain Volumes and Clinical Features in CAH Youth 250
No associations were seen between brain volumes and CAH clinical features (data not 251 shown), including markers of androgen excess (e.g., BA SD), total testosterone and 252 androstenedione levels, 17-hydroxyprogesterone, or glucocorticoid daily dose (Table 1) . 253
Finally, sensitivity analyses were performed for significant findings excluding the three 254 CAH patients with brain anomalies. Results were nearly identical, although some regions, 255
including the total left hippocampus, bilateral superior frontal cortex, and the relative volume 256 fraction of CA1, became trend-level, and the left caudal middle frontal cortex was no longer 257 significant (Table 5) . 258
DISCUSSION 259
Our study quantified regional differences in gray matter morphometry of the prefrontal 260 cortex, hippocampus, and amygdala in youth affected with classical CAH and age-and sex-261 matched controls. We found smaller total volumes of the amygdala and hippocampus in CAH 262 youth, similar to prior findings (15, 35) , and expanded upon these findings to show regional 263 volume differences in the prefrontal cortex (smaller volumes of the superior and caudal middle 264 frontal cortex), lateral nucleus of the amygdala, and subiculum and CA1 subregions of the 265 hippocampus in CAH youth compared to controls. We also found CAH youth to have smaller 266 intracranial volumes and increased cerebral spinal fluid, signifying whole brain atrophy as well 267 as regional specific alterations in the prefrontal and medial temporal lobe regions during 268 childhood and adolescent development. 269
Over the last two decades, excluding various case studies (36-38), only a small number of 270 experimental MRI studies have examined gray matter volumes in children and adults affected 271 with CAH. The first study included 39 patients (3 months to 26 years old), 11 of whom displayed 272 temporal lobe atrophy on T1-and T2-weighted MRI; albeit the study design did not include a 273 true control group (39). Another study quantified total amygdala and hippocampal volumes in 274 children with CAH as compared to controls, showing smaller amygdala volumes but no 275 difference in hippocampal volumes, in both males and females with CAH (35). These findings 276 are in contrast, however, to a more recent study that found only a trend-level difference in the 277 left amygdala and a significantly smaller right hippocampus in 19 adult women with CAH 278 compared to unaffected women (15). Of note, the latter two studies also reported global level 279 differences in brain structure, including trend-level differences in total cerebral volume in female 280 youth with CAH (35) and increased CSF in adult women with CAH (15). Our findings suggest 281 both smaller intracranial volumes, as well as increased CSF, in both males and females with 282 CAH using a higher-resolution MRI scan and both T1-and T2-weighted images to improve 283 accuracy in quantifying gray and white matter boundaries. Although we found that, in general, 284 total bilateral amygdala and hippocampal volumes were smaller in CAH compared to matched 285 controls, the differences in absolute amygdala and hippocampal volumes between CAH and 286 control youth may be a consequence of overall smaller brain volumes given that group 287 differences exist in ICV. After accounting for smaller intracranial volumes in our final models, 288 only the left hippocampus was significantly smaller in both males and females with CAH 289 compared to control youth, suggesting that differences in the amygdala may be a function of 290 global differences in brain volumes, whereas the smaller left hippocampal volume is not a 291 function of the overall difference in brain size. 292
Our interest in examining the PFC, amygdala, and hippocampus in CAH stems from the 293 high concentrations of androgens, as well as mineralocorticoid and glucocorticoid receptors, in 294 these neural regions (4,40-42). However, both the amygdala and the hippocampal formation have 295 heterogeneous subregions in terms of their cytoarchitecture and projections (43, 44) . A major 296 signaling pathway of the hippocampus, known as the perforant path, includes projections from 297 the entorhinal cortex to both the DG and CA3, and then onto the CA1, hippocampal subfields. 298
The DG is comprised of dense granule cells that send their projections, known as mossy fibers, 299 to CA3, whereas the pyramidal cells in CA3 send their axons, known as the Schaffer collaterals, tests or other brain biomarkers (15), we and others have not yet found markers of glucocorticoid 318 or androgen exposure to predict amygdala or hippocampal volumes (15, 35) . Moreover, group 319 differences did not significantly differ between the sexes (i.e., group*sex interaction terms were 320 not significant in any of our models), suggesting that both males and females with CAH are 321 equally affected. In addition, well-known sex differences, in regard to females having smaller 322 gray matter volumes compared to males, were preserved in youth with CAH. It is feasible that 323 amygdala, hippocampus, and PFC volumes may be smaller as a result of their potentially 324 diminished role in neural regulation of the hypothalamic-pituitary-adrenal (HPA) axis, as a result 325 of primary adrenal insufficiency in CAH (46). Those with other pediatric clinical disorders 326 associated with HPA dysfunction, such as hypercortisolism seen in Cushing syndrome, also have 327 been shown to have smaller total brain volumes, including the amygdala and hippocampus. In 328 addition, suppressed cortisol awakening responses have also been associated with smaller PFC 329 and hippocampal volumes in individuals at high risk for psychosis based on desensitized HPA 330 responsivity (47). Further support for this idea may stem from both absolute and proportionately 331 smaller volumes localized to the subiculum and CA1 hippocampal subfields in youth with CAH, 332 as the CA1 responds to glucocorticoids in a dose-response fashion and the subiculum plays a key 333 role in inhibiting the HPA axis (48, 49) . Taken together, these data suggest that disruptions of 334 HPA homeostasis may result in altered amygdala, hippocampus, and PFC volumes (50). 335
Alternatively, a lack of association between brain volumes and exposures due to treatment or 336 hormone concentrations may be muddled by individual differences in glucocorticoid-related 337 genes, which may otherwise complicate hormone concentrations and clearance, as well as 338 physiological neural responses (51). In addition, neurologic impairments, including possible 339 brain injury, may result from adrenal crises associated with CAH which merits further study (7) . 340
More research is needed to better understand the biological mechanisms that may contribute to 341 regional atrophy of the amygdala, hippocampus, and PFC in youth with CAH. 342
Strengths of the current study include the high-resolution T1-and T2-weighted MRI 343 approach allowing for more accurate quantification of tissue as well as segmentation of the 344 amygdala and hippocampus into distinct subregions. Although equal or larger than previous 345 studies (15,35), our CAH sample size is still relatively small, which may have limited our ability 346 to detect small-to-medium effects. In addition, the composition of CAH participants in our study 347 limited our ability to compare salt-wasting vs simple-virilizing forms, as the majority of patients 348 were salt-wasters. Other studies have included mostly patients with the salt-wasting form (15) differences, and common patterns of altered brain structure, by clinical CAH phenotype and 358 concurrent brain anomalies. Lastly, the current study was designed to examine structural 359 differences in a priori gray matter in CAH vs control youth. However, studies have also 360 suggested impairments in white matter (15,39) as well as brain function (7, 8, 10, 11, 13) in patients 361 with CAH. Thus, studies are currently underway to probe additional brain structural and 362 functional abnormalities as a focus of future research. 363
We conclude that youth affected with classical CAH have overall smaller intracranial 364 volumes as well as regional atrophy in the prefrontal cortex, amygdala, and hippocampus as 365 compared to healthy controls, suggesting brain alterations are associated with CAH during 366 childhood and adolescent development. Future studies to determine if volumetric differences in 367 the PFC, lateral nucleus of the amygdala, subiculum and CA1 hippocampal subregions map onto 368 physiological and behavioral phenotypes are needed in patients with CAH. Absolute lateral nucleus of the amygdala (LA) volumes were significantly smaller in CAH as 553 compared to control youth (*** p ≤ 0.001). B) Absolute subiculum and CA1 volumes were 554 significantly smaller in CAH compared to control youth (*p ≤ 0.05 and ** p ≤ 0.01, 555 respectively). Relative volume fractions were also significantly smaller for the presubiculum (** 556 p ≤ 0.01), subiculum (** p ≤ 0.01), and CA1 (* p ≤ 0.05) in CAH compared to control youth. 557
Relative volume fractions were also significantly larger for the CA3 subfield (** p ≤ 0.01). C) 558 3D rendering of amygdala (light gray) and hippocampal regions (dark gray) on a representative 559 CAH participant with significantly smaller absolute volumes per region in CAH compared to 560 control youth (black). 
